Functional expression of adrenoreceptors in mesenchymal stromal cells derived from the human adipose tissue

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 9, 2014, Pages 1899-1908

  Kotova, Polina D ^a   Sysoeva, Veronika Yu ^b   Rogachevskaja, Olga A ^a   Bystrova, Marina F ^a   Kolesnikova, Alisa S ^a   Tyurin Kuzmin, Pyotr A ^b   Fadeeva, Julia I ^b   Tkachuk, Vsevolod A ^b   Kolesnikov, Stanislav S ^a  

^a INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Adrenergic receptor; Calcium induced calcium release; Mesenchymal stromal cell

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPRENOLOL; AZEPEXOLE; BETA 2 ADRENERGIC RECEPTOR; CALCIUM ION; G PROTEIN COUPLED RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ISOPRENALINE; NORADRENALIN;

ABDOMINAL SUBCUTANEOUS FAT; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL PROLIFERATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; ULTRAVIOLET RADIATION;

ADRENERGIC RECEPTOR; CA(2+) UNCAGING; CALCIUM-INDUCED CALCIUM RELEASE; IP(3) RECEPTOR; MESENCHYMAL STROMAL CELL;

ADIPOSE TISSUE; ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ADULT; CALCIUM; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MODELS, BIOLOGICAL; NOREPINEPHRINE; PHOSPHATIDYLINOSITOLS; RECEPTORS, ADRENERGIC; SIGNAL TRANSDUCTION;

EID: 84902438478     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.05.002     Document Type: Article

References (49)

1. Watt F.M., Hogan B.L. Out of Eden: stem cells and their niches. Science 2000, 287:1427-1430.
2. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006, 119:2204-2213.
3. Wagner W., Ho A.D. Mesenchymal stem cell preparations - comparing apples and oranges. Stem Cell Rev. 2007, 3:239-248.
4. Kalinina N.I., Sysoeva V.Yu., Rubina K.A., Parfenova Ye.V., Tkachuk V.A. Mesenchymal stem cells in tissue growth and repair. Acta Nat. 2011, 3:30-37.
5. Phinney D.G. Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J. Cell. Biochem. 2012, 113:2806-2812.
6. Tremain N., Korkko J., Ibberson D., Kopen G.C., DiGirolamo C., Phinney D.G. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells 2001, 19:408-418.
7. Baddoo M., Hill K., Wilkinson R., Gaupp D., Hughes C., Kopen G.C., Phinney D.G. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell. Biochem. 2003, 89:1235-1249.
8. Boregowda S.V., Phinney D.G. MSCs: paracrine effects. Mesenchymal Stromal Cells: Biology and Clinical Applications 2013, 145-167. Springer, New York. P. Hematti, A. Keating (Eds.).
9. 2+ oscillations and its transporters in mesenchymal stem cells. Physiol. Res. 2010, 59:323-329.
10. Pillozzi S., Becchetti A. Ion channels in hematopoietic and mesenchymal stem cells. Stem Cells Int. 2012, 217910.
11. Leclerc C., Néant I., Moreau M. The calcium: an early signal that initiates the formation of the nervous system during embryogenesis. Front. Mol. Neurosci. 2012, 5:3.
12. Resende R.R., Andrade L.M., Oliveira A.G., Guimarães E.S., Guatimosim S., Leite M.F. Nucleoplasmic calcium signaling and cell proliferation: calcium signaling in the nucleus. Cell Commun. Signal. 2013, 11:14.
13. Rosenberg S.S., Spitzer N.C. Calcium signaling in neuronal development. Cold Spring Harb. Perspect. Biol. 2011, 3:a004259.
14. Blackiston D.J., McLaughlin K.A., Levin M. Bioelectric controls of cell proliferation ion channels, membrane voltage and the cell cycle. Cell Cycle 2009, 8:3527-3536.
15. Sundelacruz S., Levin M., Kaplan D.L. Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev. Rep. 2009, 5:231-246.
16. Becchetti A. Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am. J. Physiol. Cell Physiol. 2011, 301:255-265.
17. Hoffmann E.K., Lambert I.H., Pedersen S.F. Physiology of cell volume regulation in vertebrates. Physiol. Rev. 2009, 89:193-277.
18. Cuddapah V.A., Sontheimer H. Ion channels and transporters in cancer. 2. Ion channels and the control of cancer cell migration. Am. J. Physiol. 2011, 301:541-549.
19. + and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and β1 integrins. J. Exp. Med. 2000, 191:1167-1176.
20. Wei J.-F., Wei L., Zhou X., Lu Z.Y., Francis K., Hu X.Y., Liu Y., Xiong W.C., Zhang X., Banik N.L., Zheng S.S., Yu S.P. Formation of Kv2.1-FAK complex as a mechanism of FAK activation, cell polarization and enhanced motility. J. Cell. Physiol. 2008, 217:544-557.
21. + channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood 2007, 110:1238-1250.
22. Cidad P., Jimenez-Perez L., Garcia-Arribas D., Miguel-Velado E., Tajada S., Ruiz-McDavitt C., Lopez-Lopez J.R., Perez-Garcia M.T. Kv1.3 channels can modulate cell proliferation during phenotypic switch by an ion-flux independent mechanism. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1299-1307.
23. Xu S.-Z., Zeng F., Boulay G., Grimm C., Harteneck C., Beech D.J. Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br. J. Pharmacol. 2005, 145:405-414.
24. 2+ channels in PC12 cells. Cell. Signal. 2010, 22:1420-1426.
25. Harteneck S., Gollasch M. Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 shannels. Curr. Pharm. Biotechnol. 2011, 12:35-41.
26. Berg K.A., Clarke W.P., Sailstad C., Saltzman A., Maayani S. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol. Pharmacol. 1994, 46:477-484.
27. 2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J. Biol. Chem. 2004, 279:18990-18997.
28. Baryshnikov S.G., Rogachevskaja O.A., Kolesnikov S.S. Calcium signaling mediated by P2Y receptors in mouse taste cells. J. Neurophysiol. 2003, 90:3283-3294.
29. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signaling: dynamics, homeostasis and remodeling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
30. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
31. 2+ signaling and its physiological roles. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 2010, 86:244-256.
32. Ellis-Davies G.C. Caged compounds: photorelease technology for control of cellular chemistry and physiology. Nat. Methods 2007, 4:619-628.
33. Dupont G., Combettes L., Leybaert L. Calcium dynamics: spatio-temporal organization from the subcellular to the organ level. Int. Rev. Cytol. 2007, 261:193-245.
34. Park J.B., Lee C.S., Jang J.H., Ghim J., Kim Y.J., You S., Hwang D., Suh P.-G., Ryu S.H. Phospholipase signalling networks in cancer. Nat. Rev. Cancer 2012, 12:782-792.
35. Kawamoto E.M., Vivar C., Camandola S. Physiology and pathology of calcium signaling in the brain. Front. Pharmacol. 2012, 3:61.
36. 2+ signaling pathways in human mesenchymal stem cells. Cell Calcium 2002, 32:165-174.
37. Guimaraes S., Moura D. Vascular adrenoceptors: an update. Pharmacol. Rev. 2001, 2:319-356.
38. Salem H.K., Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010, 28:585-596.
39. 1-adrenergic receptors: diversity of signaling networks and regulation. J. Recept. Signal Transduct. Res. 2010, 30:410-419.
40. Cottingham C., Chen H., Chen Y., Peng Y., Wang Q. Genetic variations of a2-adrenergic receptors illuminate the diversity of receptor functions. Advances in Adrenergic Receptor Biology 2011, 162-190. Academic Press, San Diego. Q. Wang (Ed.).
41. Lynch G.S., Ryall J.G. Role of β-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol. Rev. 2008, 88:729-767.
42. Shenoy S.K., Drake M.T., Nelson C.D., Houtz D.A., Xiao K., Madabushi S., Reiter E., Premont R.T., Lichtarge O., Lefkowitz R.J. β-Arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor. J. Biol. Chem. 2006, 281:1261-1273.
43. Patel C.B., Noor N., Rockman H.A. Functional selectivity in adrenergic and angiotensin signaling systems. Mol. Pharmacol. 2010, 78:983-992.
44. Rajagopal S., Rajagopal K., Lefkowitz R.J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 2010, 9:373-386.
45. Kim I.-M., Tilley D.G., Chen J., Salazar N.C., Whalen E.J., Violin J.D., Rockman H.A. β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14555-14560.
46. Coffa S., Breitman M., Hanson S.M., Callaway K., Kook S., Dalby K.N., Gurevich V.V. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation. PLoS One 2011, 6:e28723.
47. Palmer A.E., Tsien R.Y. Measuring calcium signaling using genetically targetable fluorescent indicators. Nat. Protoc. 2006, 1057-1065.
48. 2+ signaling. Cell. Signal. 2003, 15:243-253.
49. 2+ release channel. J. Biol. Chem. 2006, 281:20825-20833.